← SynDRA
MELPHALAN
SynDRA canonical compound SYN0002219 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Mechanism of action | DNA alkylating agent | DNA inhibitor |
|---|
| Indication | multiple myeloma |
|---|
| Disease area | hematologic malignancy |
|---|
All known targets
Mechanisms of action (all sources)
- DNA alkylating agent
- DNA inhibitor
Drug classes
- Alkylating Activity
- Alkylating Drug
- Alkylating Agents
- Antineoplastic Agents
- Antineoplastic Agents, Alkylating
- Immunologic Factors
- Immunosuppressive Agents
- Myeloablative Agonists
- Noxae
ATC classes
Cross-references
Synonyms
- melphalan hydrochloride
- alkeran
- levofalan
- levofolan
- levopholan
- melfalan
- phenylalanine mustard
- sarcoclorin
- melphalan HCl
- Melfalan
- Alanine nitrogen mustard
- L-pam
- L-phenylalanine mustard
- L-sarcolysin
- Phenylalanine mustard
- Sarcolycin, l-
- CB-3025
- NCI-C04853
- NSC-241286
- NSC-8806
- SK-15673
- Alkeran
- Levofalan
- Levofolan
- Levopholan
- Melfalano
- Melphalanum
- Alanine Nitrogen Mustard
- Phenylalanine nitrogen mu stard
- Phenylalanine nitrogen mustard
- AY3360000
- ALKERAN (TN)
- At-290
- L-PAM
- L-Phenylalanine mustard
- L-Sarcolysin
- L-Sarcolysine
- L-Sarkolysin
Reported adverse events
- Hypersensitivity
- Hypersensitivity reaction
- Myelosuppression
- Cardiac arrest
- Injection
- Dizziness
- Fatigue
- Nausea
- Pyrexia
- Vomiting
- Activated partial thromboplastin time
- Activated partial thromboplastin time prolonged
Look up MELPHALAN in the interactive SynDRA portal →